karine dubÉ, drph...curriculum vitae – karine dubé page 3 of 25 2006 – 2007 program...

Last Updated: February 12, 2020

Curriculum Vitae – Karine Dubé Page 1 of 25

KARINE DUBÉ, DrPH Email: [email protected]

Cell Phone: (919) 259-2489

EDUCATION GILLINGS SCHOOL OF GLOBAL PUBLIC HEALTH UNIVERSITY OF NORTH CAROLINA-CHAPEL HILL, NC Health Policy and Management (HPM) Doctorate of Public Health (DrPH) Graduated in May 2016 OXFORD UNIVERSITY, Oxford, England Master of Philosophy in Development Studies/International Health (MPhil) Graduated in July 2005 with Distinction

UNIVERSITY OF NORTH CAROLINA-CHAPEL HILL, NC B.A. in International Studies, Concentration in Global Health Minor in Business Administration (Kenan-Flagler Business School) GPA: 3.974/4.000. Graduated in May 2003 with Highest Honors

PROFESSIONAL EXPERIENCE 2017 – Present ASSISTANT PROFESSOR, Public Health Leadership Program (PHLP),

SOCIO-BEHAVIORAL RESEARCHER, HIV Cure-Related Research UNC-Chapel Hill Gillings School of Global Public Health

• Lead instructor for global health courses in the Public Health Leadership Program (PHLP) and Global Health Concentration, including:

o Introduction to Global Public Health (SPHG 700) (online) o Critical Issues in Global Health (PUBH 711) (residential and online) o Global Health Ethics (PUBH 712) (online) o AIDS Course (PUBH 725) (online)

• Lead socio-behavioral scientist on HIV cure-related clinical trial protocols 2016 ADJUNCT ASSISTANT PROFESSOR, Public Health Leadership Program (PHLP),

UNC-Chapel Hill Gillings School of Global Public Health

• Lead instructor for global health courses in the Public Health Leadership Program (PHLP) and Global Health Concentration, including:

o Introduction to Global Public Health (SPHG 700) o Global Health Ethics (PUBH 712)

2016 – 2017 CONSULTANT/CO-INVESTIGATOR, Social and Ethical Aspects of HIV Cure Research (searcHIV), UNC-Chapel Hill, Chapel Hill, NC

• Leading inter-disciplinary research and publications related to the social sciences of HIV cure research in the United States.

2016 CLINICAL PROJECT MANAGER, ClinicalRM, Chapel Hill, NC

• Managed all aspect of complex Ebola research program funded by the Bill and Melinda Gates Foundation in West Africa, with a special focus on natural history study of Ebola Virus Disease (EVD) in Monrovia, Liberia.

• Managed the UNC – ClinicalRM – Duke – USAMRIID Ebola Research Consortium.

mailto:[email protected]



2013 – 2015 RESEARCH PROGRAM MANAGER, Institute of Global Health and Infectious Diseases (IGHID), Collaboratory of AIDS Researchers for Eradication (CARE), The University of North Carolina at Chapel Hill, NC.

• Managed a large NIH-funded Collaboratory compromised of 20+ scientists from 10+ universities in the United States and Europe ($USD 6.4 million/year) whose main objective was to pursue a concerted effort to eradicate HIV infection by bringing a team of experts together in discovery and development to create a cure for AIDS. The Administrative Core was a key component for the success of the Collaboratory by overseeing the various activities of the research program and providing infrastructure and coordination between the various scientific groups and the scientific cores.

• Designed and managed an international HIV cure research training curriculum (CUREiculum) with partner organizations such as DARE, defeatHIV, Project Inform, and AVAC.

• Built networks between the HIV+ community and the scientists working on HIV cure-related research, convening meetings of community advisory boards, disseminating information, and providing community feedback to the scientists on their research.

2012 – 2013 CLINICAL RESEARCH ASSOCIATE III, U.S. Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), Bethesda, MD.

• Managed site and cohort development program in preparation for future prime-boost HIV vaccine trials in Mozambique, transitioned project to U.S. Department of Defense and U.S. National Institutes of Health Division of AIDS funding streams, developed and designed HIV incidence research in Mozambique, prepared manuscripts for Mozambique scientific journal articles, assisted in the preparation of the U.S. Military HIV Research Program Clinical Trials Unit application for the U.S. NIH DAIDS Clinical Research Sites re-competition, developed standard operating procedures for MHRP Clinical Operations Office.

2008 – 2012 SENIOR RESEARCH ASSOCIATE, FHI 360 (formerly Family Health International), Research

Triangle Park, NC.

• Developed, designed and oversaw major components of studies in infectious diseases, oversaw research implementation activities in the field, prepared scientific reports, collaborated with team members and field investigators throughout all phases of research, oversaw submissions to ethical and institutional review boards, developed and monitored financial aspects of studies, provided technical oversight for preparation of proposals, protocols, research instruments and study procedures manuals, developed and reviewed protocols and study-related materials for assigned clinical research studies, oversaw clinical monitoring of studies, ensured that research was conducted in accordance with applicable federal regulations and FHI 360 policies and standard operating procedures, participated in clinical monitoring of studies, trained junior research staff in clinical research monitoring and management, assisted in development of research proposals and business development.

2007 – 2008 RESEARCH AND PROGRAM ANALYST, amfAR – The Foundation for AIDS Research, Washington, DC.

• Researched and analyzed biomedical and behavioral research results, and compiled research developments pertaining to HIV/AIDS prevention, treatment, care, and policy.

• Co-authored issue briefs, fact sheets and policy briefs on various topics related to HIV/AIDS.

• Developed a strategic plan for the public policy department.

• Assisted in the planning, development, and execution of amfAR’s programmatic activities.

• Represented amfAR at meetings and conferences and promoted amfAR’s positions and policy priorities to colleague organizations and government agencies, including USAID, National Institutes of Health (NIH), and Office of the Global AIDS Coordinator.

• Provided technical assistance to amfAR’s Therapeutics Research, Education and AIDS Training (TREAT) Asia program.

• Created and maintained libraries of articles on several topics related to HIV/AIDS for the organization.

• Conducted training workshops on HIV/AIDS-related issues; supervised 5 junior staff.



2006 – 2007 PROGRAM COORDINATOR, Health Strategies International, LLC, Durham, NC.

• Conducted consultancy work on human resources for malaria scale-up activities for the Bill and Melinda Gates Foundation/PATH Malaria Control and Evaluation Partnership (MACEPA) project in Zambia.

• Provided technical assistance on USAID-funded Jamaica Health Lifestyle Project and USAID-funded Romanian Health Care Reform Project.

• Maintained project budgets and reviewed work plans, project timelines and scopes of work.

• Acted as Manager of Business Development. Assisted in the preparation of project proposals, including a successful sub-contract on USAID/PATH TASC 2 Global Tuberculosis Task Order.

• Expanded business relationships with partner organizations and donors. Created a database of business opportunities and enrolled the company with funders’ email list servers.

• Supervised 4 in-country staff. 2005 – 2006 SENIOR RESEARCH ASSISTANT, Family Health International, Research Triangle Park, NC.

• Clinical monitor for African sites conducting 6% Cellulose Sulfate gel phase III trial. Verified source data, wrote and resolved queries using electronic databases, reviewed the quality and integrity of data collected from the sites.

• Maintained regulatory documents for multiple study sites and ensured that the study was in accordance with GCP and other international clinical guidelines.

• Served as the primary contact and coordinated correspondence between the study sites, the sponsors and the in-house staff.

• Reviewed documents for successful implementation, coordination and management of study projects.

HONORS 2015 Arthur B. Holzworth Endowed Scholarship in Health Leadership, UNC-Chapel Hill 2005 Distinction (upon graduation), Queen Elizabeth House, Oxford University 2003-2005 Rhodes Scholarship 2003 Douglas Eyre International Studies Award (Best Senior Honors Thesis) Robert E. Bryan Distinguished Service Award 2002 Jane Craig Gray Memorial Award (Most Outstanding Junior Woman) James Henley Thompson & Evelyn Barnett Thompson Research Award Order of the Golden Fleece Honor Society Order of the Old Well Honor Society Ford Motor Company Golden Key Undergraduate Scholarship 2001 Order of the Grail-Valkyries Honor Society Golden Key National Honor Society 2000-2003 North Carolina Fellows Program University of North Carolina Honors Program 1999-2003 Morehead Scholarship Dean’s List (all semesters)

MEMBERSHIPS International AIDS Society (IAS) American Public Health Association (APHA) – HIV/AIDS and Ethics Sections Consortium of Universities for Global Health (CUGH) One Health



BIBLIOGRAPHY AND PRODUCTS OF SCHOLARSHIP

Submitted (Under Review) Journal Articles • K. Dubé, L. Hosey, K. Starr, L. Barr, D. Evans, E. Hoffman, D.M. Campbell, J. Simoni, J. Sugarman, J. Sauceda, B.

Brown, K.L. Diepstra, C. Godfrey, D.R. Kuritzkes, D.A. Wohl, R. Gandhi, E. Scully. Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group (ACTG) 5366. Submitted in AIDS Research and Human Retroviruses (approximately 12 pages).

• K. Dubé, L. Dee. Willingness to Risk Death Endpoint in HIV Cure-Related Research with Otherwise Healthy Volunteers is Misleading. Submitted in Journal of Virus Eradication (approximately 2 pages).

• K.E. Perry, K. Dubé, S. Concha-Garcia, H. Patel, A. Kaytes, J. Taylor, S.S. Javadi, K. Mathur, M. Lo, B. Brown, J.A. Sauceda, D.A. Wohl, S. Little, S. Hendrickx, S.A. Rawlings, D.M. Smith, S. Gianella. “My Death Will Not [Be] in Vain”: Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life. Submitted in AIDS Research and Human Retroviruses (approximately 12 pages).

• K. Dubé, H. Patel, S. Concha-Garcia, K.E. Perry, K. Mathur, S.S. Javadi, J. Taylor, A. Kaytes, B. Brown, J.A. Sauceda, S. Little, S. Hendrickx, S.A. Rawlings, D.M. Smith, S. Gianella. “What Better Way to Leave this World”: Perceptions of Next-of-Kin/Loved Ones about Last Gift Rapid Research Autopsy Study Enrolling People with HIV/AIDS at the End of Life”. Submitted in AIDS Research and Human Retroviruses (approximately 12 pages).

• P. Saberi, S. Eskaf, J.A. Sauceda, D. Evans, K. Dubé. Perceptions of HIV Virologic Control Strategies among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. Submitted in AIDS Research and Human Retroviruses (approximately 12 pages).

• B. Brown, J. Taylor, K. Dubé, D. Kuzmanović, Y. Long, L. Marg. Lessons Learned in the Ethical Conduct of HIV Research with Community Members: A Case Study. Submitted in Ethics & Human Research (approximately 8 pages).

In Press

• M. J. Peluso, L. Dee, D. Campbell, J. Taylor, R. Hoh, R.L. Rutishauser, J. Sauceda, S. G. Deeks, K. Dubé. A Collaboratory, Multi-Disciplinary Approach to Risk Mitigation during HIV Analytical Treatment Interruption. In press in Journal of Virus Eradication (approximately 3 pages).

Peer-Reviewed Journal Articles

1. M. Y. Karris, K. Dubé, A. A. Moore. What Lessons it Might Teach Us! Community Engagement in HIV Research. Current Opinion in HIV/AIDS 2020; 15(2): 142 – 49. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31895141.

2. S. Tozay, W.A. Fischer, D.A. Wohl, K. Kilpatrick, F. Zou, E. Reeves, K. Pewu, K. DeMarco, A.J. Loftis, K. King, D. Grant, J. Schieffelin, G. Gorvego, H. Johnson, T. Conneh, G. Williams, J.A.E. Nelson, D. Hoover, D. McMillian, C. Merenbloom, D. Hawks, K. Dubé, J. Brown. Long-Term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation. Clinical Infect Dis 2019 [Epub ahead of print] PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31693114.

3. K. Dubé, S. Eskaf, D. Evans, J. Sauceda, P. Saberi, B. Brown, D. Averitt, K. Martel, M. Meija, D. Campbell, L. Barr, J.

Kanazawa, K. Perry, H. Patel, S. Luter, T. Poteat, J.D. Auerbach, D.A. Wohl. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Research and Human Retroviruses 2019 [Epub ahead of print] PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31608651.

https://www.ncbi.nlm.nih.gov/pubmed/31895141https://www.ncbi.nlm.nih.gov/pubmed/31693114https://www.ncbi.nlm.nih.gov/pubmed/31608651



4. K. Dubé, J. D. Auerbach, M. J. Stirratt, P. Gaist. Applying the Functional Behavioral and Social Sciences Research (BRRS) Framework to HIV Cure-Related Research. Journal of the International AIDS Society (JIAS) 2019; 22: e25404. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31665568.

5. L. Dee, C.A. Boone, D. Palm, D. Campbell, K. Dubé. Secondary HIV Infection and Mitigation in Cure-Related HIV

Trials During Analytical Treatment Interruptions. Journal of Infectious Diseases 2019; 220(7): 1230 – 1. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31505661

6. B. Brown, L. Marg, Z. Zhang, D. Kuzmanović, K. Dubé, J. Galea. Factors Associated with Payments to Research

Participants: A Review of Socio-Behavioral Studies at a Large Southern California Research University. Journal of Empirical Research on Human Research Ethics (JERHRE) 2019; 14(4): 408 – 15. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31432735

7. K. Dubé, J. Simoni, M. Louella, L. Sylla, Z.H. Mohamed, H. Patel, S. Luter, A.C. Collier. Acceptability of Cell and Gene Therapy for Curing HIV Infection among People Living with HIV in the Northwestern United States: A Qualitative Study. AIDS Research and Human Retroviruses 2019 Apr 16. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30990052

8. L. Newton, R. Necochea, D. Palm, J. Taylor, L. Barr, H. Patel, A. Nathan, J. Gerrard, L. Sylla, B. Brown, K. Dubé. Revisiting the ‘Sterilising Cure’ Terminology: A Call for More Patient-Centered Perspectives on HIV Cure-Related Research. Journal of Virus Eradication 2019; 5: 122 – 4. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31191916.

9. M. M. Danielson, K. Dubé. Michael’s Testimonial. Annals of Internal Medicine 2019; 170(7): 511 – 2. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30934078

10. B. Julg, L. Dee, J. Ananworanich, D. Barouch, K. Bar, M. Caskey, D. Colby, L. Dawson, K. Dong, K. Dubé, J. Eron, J. Frater, R. Gandhi, R. Geleziunas, P. Goulder, G. Hanna, R. Jefferys, R. Johnston, D. Kuritzkes, J. Li, U. Likhitwonnawut, J. van Lunzen, J. Martinez-Picado, V. Miller, L. Montaner, D. Nixon, D. Palm, G. Pantaleo, H. Peay, D. Persaud, J. Salzwedel, K. Salzwedel, T. Schacker, V. Sheikh, O. Søgaard, S. Spudich, K. Stephenson, J. Sugarman, J. Taylor, P. Tebas, C. Tiemessen, R. Tressler, C. Weiss, S. Zheng, M. Robb, N. Michael, J. Mellors, S. Deeks, B. Walker. Recommendations for Analytical Treatment Interruption in HIV Remission Trials – Report of a Consensus Workshop. Lancet HIV 2019; 6(4): e259 – 68. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30885693

11. K. Dubé, L. Barr, D. Palm, B. Brown, J. Taylor. Putting Participants at the Centre of HIV Cure Research. Lancet HIV

2019; 6(3): e147 – 9. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30772419

12. L. Overholt, D.A. Wohl, W. Fischer, D. Westreich, S. Tozay, E. Reeves, K. Pewu, D. Adjasoo, D. Hoover, C. Merenbloom, J. Johnston, G. Williams, T. Conneh, J. Diggs, A. Buller, D. MacMillan, D. Hawks, K. Dubé, J. Brown. Stigma and Ebola Survivorship in Liberia: Results from a Longitudinal Cohort Study. PLoS One 2018; 13(11): e0206595. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30485311

13. K. Dubé, S. Gianella, S. Concha-Garcia, S. Little, A. Kaytes, J. Taylor, K. Mathur, S. Javadi, A. Nathan, H. Patel, S. Luter, S. Philpott-Jones, B. Brown, D. Smith. Ethical Considerations for HIV Cure-Related Research at the End of Life. BMC Medical Ethics 2018; 19(1): 83. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30342507

14. M.M. Danielson, K. Dubé. Michael’s Testimonial. Annals of Internal Medicine 2018; 169(5): 349. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30178018

15. B. Brown, C. Ortiz, K. Dubé. Assessment of the Right-to-Try Law. Journal of Nuclear Medicine 2018; 59(1): 1 – 2. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30097502

https://www.ncbi.nlm.nih.gov/pubmed/31665568https://www.ncbi.nlm.nih.gov/pubmed/31505661https://www.ncbi.nlm.nih.gov/pubmed/31432735https://www.ncbi.nlm.nih.gov/pubmed/30990052https://www.ncbi.nlm.nih.gov/pubmed/31191916https://www.ncbi.nlm.nih.gov/pubmed/30934078https://www.ncbi.nlm.nih.gov/pubmed/30885693https://www.ncbi.nlm.nih.gov/pubmed/30772419https://www.ncbi.nlm.nih.gov/pubmed/30485311https://www.ncbi.nlm.nih.gov/pubmed/30342507https://www.ncbi.nlm.nih.gov/pubmed/30178018https://www.ncbi.nlm.nih.gov/pubmed/30097502



16. K. Prakash, S. Gianella, K. Dubé, J. Taylor, G. Lee, DM. Smith. Willingness to Participate in HIV Research at the End of Life (EOL). PLoS One 2018; 13(7): e0199670. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30036365

17. B. Brown, J. Galea, K. Dubé, P. Davidson, K. Khoshnood, L. Holtzman, L. Marg, J. Taylor. The Need to Track Payment Incentives to Participate in HIV Research. IRB: Ethics & Human Research 2018 (July – August). PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30387975

18. K. Dubé, S. Luter, B. Lesnar, L. Newton, J. Galea, B. Brown, S. Gianella. Use of ‘Eradication’ in HIV Cure-Related Research: A Public Health Debate. BMC Public Health 2018; 18:245. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29439706

19. K. Dubé, L. Sylla, L. Dee, J. Taylor, D. Evans, C.D. Bruton, A. Gilbertson, L. Gralinski, B. Brown, A. Skinner, B. J. Weiner, S. B. Greene, A. Corneli, A. Adimora, J.D. Tucker, S. Rennie. Research on HIV Cure. Mapping the Ethics Landscape. PLoS Medicine 2017; 14(12): e1002470. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29220353

20. L. Sylla, D. Evans, J. Taylor, A. Gilbertson, D. Palm, J. Auerbach, K. Dubé. If We Build It, Will They Come? Perceptions of HIV Cure Research by People Living with HIV in Four U.S. Cities – A Qualitative Focus Group Study. AIDS Research and Human Retroviruses 2017. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29198134

21. K. Dubé, L. Sylla, L. Dee. Reply to Commentary: “Are HIV Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy.” Journal of Empirical Research on Human Research Ethics (JERHRE) 2017. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29179626

22. Brown B, Galea JT, Dubé K. Crucial but Understudied: Incentives in HIV Research. Lancet HIV 2017. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29170029

23. K. Dubé, L. Dee, D. Evans, L. Sylla, J. Taylor, B. Brown, V. Miller, A. Corneli, A. Skinner, S. Greene, J. Tucker, S.

Rennie. Perceptions of Equipoise, Risk/Benefit Ratios, and ‘Otherwise Healthy Volunteers’ in the Context of Early-Phase HIV Cure Research in the United States – A Qualitative Inquiry. Journal of Empirical Research on Human Research Ethics (JERHRE) 2017. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28984168

24. Fischer W.A. II, J. Brown, D. Wohl, A.J. Loftis, S. Tozay, E. Reeves, K. Pewu, G. Gorvego, S. Quellie, C. K. Cunningham, C. Merenbloom, S. Napravnik, K. Dubé, D. Adjasoo, E. Jones, K. Bonarwolo, D. Hoover. Ebola Virus RNA Detection in Semen More than Two Years after Resolution of Acute Ebola Virus Infection. Open Forum Infectious Diseases 2017. Link: https://www.ncbi.nlm.nih.gov/pubmed/29670927

25. K. Dubé, D. Evans, L. Dee, L. Sylla, J. Taylor, A. Skinner, B.J. Weiner, S. B. Greene, S. Rennie, S. Greene. ‘We Need to Deploy Them Very Thoughtfully and Carefully’: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States – A Qualitative Inquiry. AIDS Research and Human Retroviruses 2017. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28562069

26. Garner S, S. Rennie, J. Ananworanich, K Dubé, D.M. Margolis, J. Sugarman, R. Tressler, A. Gilbertson, L. Dawson.

Interrupting Antiretroviral Treatment in HIV Cure Research: Scientific and Ethical Considerations. Journal of Virus Eradication 2017; 3: 82 – 4. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28435691

27. K. Dubé, Taylor J., Sylla L., Evans D., Dee L., Burton A., Willenberg L., Rennie S., Skinner A., Tucker J.D., Weiner B.J., Greene S.B. ‘Well, It’s the Risk of the Unknown… Right?’: A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States. PLoS One 2017; 12(1):e0170112. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28122027

https://www.ncbi.nlm.nih.gov/pubmed/30036365https://www.ncbi.nlm.nih.gov/pubmed/30387975https://www.ncbi.nlm.nih.gov/pubmed/29439706https://www.ncbi.nlm.nih.gov/pubmed/29220353https://www.ncbi.nlm.nih.gov/pubmed/29198134https://www.ncbi.nlm.nih.gov/pubmed/29179626https://www.ncbi.nlm.nih.gov/pubmed/29170029https://www.ncbi.nlm.nih.gov/pubmed/28984168https://www.ncbi.nlm.nih.gov/pubmed/29670927https://www.ncbi.nlm.nih.gov/pubmed/28562069https://www.ncbi.nlm.nih.gov/pubmed/28435691https://www.ncbi.nlm.nih.gov/pubmed/28122027



28. K. Dubé, Evans D., Sylla L., Taylor J., Weiner B., Skinner A., Thirumurthy H., Tucker J.D., Rennie S., Greene S. Willingness to Participate in HIV Cure Research: Survey Results from 400 People Living with HIV in the United States. Journal of Virus Eradication January 2017; 3(1): 40 – 50. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28275457

29. Loftis A.J., S. Quellie, K. Chason, E. Sumo, M. Toukolon, Y. Otieno, H. Ellerbrok, M.M. Hobbs, D. Hoover, K. Dubé, D.A. Wohl, W.A. Fischer II. Validation of the Cepheid GeneXpert for Detecting Ebola Virus in Semen. Journal of Infectious Diseases 2017; 215: 344-50. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27932614

30. Grossman C.I., A.L. Ross, J. D. Auerbach, J. Ananworanich, K. Dubé, J. D. Tucker, V. Noseda, C. Possas, D. Rausch,

International AIDS Society Towards an HIV Cure Initiative. Towards a Multi-Disciplinary HIV Cure Research Agenda: Integrating the Social Science with Biomedical and Clinical Research. Trends in Microbiology 2016; 24(1): 5 – 11. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=26642901

31. K. Dubé, C. Ramirez, J. Handibode, J. Taylor, A. Skinner, S. Greene, J. D. Tucker. Participation in HIV Cure Research: A Scoping Review of the Proxy Literature and Implications for Future Research. The Journal of Virus Eradication 2015; 1: e14-e20. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/26866059

32. J. Ananworanich, K. Dubé, N. Chomont. How Does the Timing of Antiretroviral Therapy Initiation in Acute Infected Affect HIV Reservoir? Current Opinion in HIV/AIDS 2015; 10(1): 18 – 28. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/25415421

33. Meque, K. Dubé, L. Bierhuizen, A. Zango, N. Veldhuijzen, F. Cumbe, P.J. Feldblum, J. v.d. Wijgert. Willingness to Participate in Future HIV Prevention Trials in Beira, Mozambique African Journal of AIDS Research 2014; 13(4): 393 – 8. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/25555105

34. K. Dubé, G.E. Henderson, D.M. Margolis. Framing Expectations in Early HIV Cure Research. Trends in Microbiology – Science and Society 2014; 22(10): 547 – 9. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/25280965

35. P.J. Feldblum, S. Enosse, K Dubé, P. Arnaldo, C. Muluana, R. Banze, A. Nhanala, J. Cunaca, P.-L. Chen, M.L. Robb, R. Thompson. HIV Prevalence and Incidence in a Cohort of Women at Higher Risk for HIV Acquisition in Chókwè, Southern Mozambique. PLoS One 2014; 9(5): e97547. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24842811.

36. K. Nanda, A. Lendvay, C. Kwok, E. Tolley, K. Dubé, V. Brache. Continuous Compared With Cyclic Use of Oral Contraceptive Pills in the Dominican Republic. Obstetrics and Gynecology 2014; 123(5): 1012 – 22. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24785854.

37. Meque, K. Dubé, P.J. Feldblum, A.C.A. Clements, A. Zango, F. Cumbe, P.L. Chen, J.J. Ferro, J.H.v.d. Wijgert. Prevalence, Incidence and Determinants of Herpes Simplex Virus Type 2 Infection among HIV-Seronegative Women at High-Risk of HIV Infection: A Prospective Study in Beira, Mozambique. PLoS One 2014; 9(2): e89705. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24586973.

38. K. Dubé, A. Zango, J.v.d. Wijgert, I. Meque, J.J. Ferro, F. Cumbe, P.L. Chen, S. Ma., E Jolles, A. Fumo, M.L. Robb, P.J. Feldblum. HIV Incidence in a Cohort of Women at Higher Risk in Beira, Mozambique: Prospective Study 2009 – 2012. PLoS One 2014; 9(1): e84979. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24475035.

39. K. Nanda, S. Delany-Moretlwe, K. Dubé, A. Lendvay, C. Kwok, L. Molife, S.Nakubulwa, V. Edward, B. Mpairwe, F. Morembe. Nevirapine-Based Antiretroviral Therapy Does Not Reduce Oral Contraceptive Effectiveness. AIDS 2013; 27(Suppl 1): S17 – S25. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24088680.

https://www.ncbi.nlm.nih.gov/pubmed/28275457https://www.ncbi.nlm.nih.gov/pubmed/27932614http://www.ncbi.nlm.nih.gov/pubmed/?term=26642901http://www.ncbi.nlm.nih.gov/pubmed/26866059http://www.ncbi.nlm.nih.gov/pubmed/25415421http://www.ncbi.nlm.nih.gov/pubmed/25555105http://www.ncbi.nlm.nih.gov/pubmed/25280965http://www.ncbi.nlm.nih.gov/pubmed/24842811http://www.ncbi.nlm.nih.gov/pubmed/24785854http://www.ncbi.nlm.nih.gov/pubmed/24586973http://www.ncbi.nlm.nih.gov/pubmed/24475035http://www.ncbi.nlm.nih.gov/pubmed/24088680



40. Zango, K. Dubé, S. Kelbert, I. Meque, F. Cumbe, P.L. Chen, J. Ferro, P.J. Feldblum, J.van de Wijgert. Determinants of Prevalent HIV Infection and Late HIV Diagnosis among Young Women with Two or More Sexual Partners in Beira, Mozambique. PLoS One 2013 8(5): e63427. http://www.ncbi.nlm.nih.gov/pubmed/23691046

41. K. Dubé, E. Hauser, C. Longfellow, A.C. Henley, W. Gesler. Disability in North Carolina: Spatial Distributions and Access to Care. North Carolina Geographer, Volume 11; 2003: 62-73. Available at: http://core.ecu.edu/crawfordt/ncgs/ncg/ncg_2003/2003_dube.pdf.

Fact Sheets/Technical Briefs 1. K. Dubé, E. Dunn-Georgiou, M. Ruiz. Women and HIV/AIDS. amfAR Fact Sheet Number 2. March 2008.

2. M. Ruiz, K. Dubé, E. Dunn-Georgiou. HIV in Correctional Settings: Implications for Prevention and Treatment

Policy. amfAR Issue Brief Number 5. March 2008. Presented at the Second Annual Academic and Health Policy Conference on Correctional Health Care.

3. M. Ruiz, K. Dubé, E. Dunn-Georgiou. The Effectiveness of Harm Reduction in Preventing the Transmission of

HIV/AIDS. amfAR Fact Sheet Number 1. Revised November 2007.

4. M. Ruiz, K. Dubé, E. Dunn-Georgiou. Assessing the Efficacy of Abstinence-Only Programs for HIV Prevention among Young People. amfAR Issue Brief Number 2. Revised October 2007.

Invited Expert Panels 1. K. Dubé (with H. Peay, J. Sugarman, L. Dawson, V. Miller, U. Likhitwonnawut). Ethics of Analytical Treatment

Interruptions (ATIs)/Intensively Monitored Antiretroviral Pauses (IMAPs). Consensus Workshop on Analytical Treatment Interruption in HIV Cure Trials. Ragon Institute of MGH, MIT and Harvard. July 2018, Boston, MD, USA.

2. K. Dubé (with J.M. Zuniga, G. Bolan, S. Wilking, D. Harvey, A. Reynolds, A.D. McNaugthen). Advances and

Interventions to End Epidemics The New Front Line of HIV, HCV, and STD Prevention and Treatment. SYNChronicity 2018, April 2018, Arlington, VA, USA.

3. K. Dubé (with N. Eyal, J. Sugarman, R. Steel, M. Agosto, D. Evans) Regulation of Clinical Research Related to HIV

Cure. Expert panel on “Setting the Stage and Expectations for Ethics and Community Engagement.” Forum for Collaborative Research, January 2018, Bethesda, MD, USA.

4. K. Dubé (with E. Scully, K. Struble, D.D. Dixon). Regulation of Clinical Research Related to HIV Cure. Expert panel on “Population-Specific issues in HIV Cure Research: Women.” Forum for Collaborative Research, January 2018, Bethesda, MD, USA.

Oral Presentations 1. K. Dubé. Women’s Involvement in HIV Cure-Related Research – Empirical Data, Unresolved Challenges and

Opportunities for the Future. Invited Oral Presentation at 2020 Pre-CROI Community HIV Cure Research Workshop, March 2020, Seattle, WA, USA.

2. K. Dubé. Research Requiring Primary Data Collection. Invited Lecture to Essentials of Practice-Based Research (HPM 953). March 2020. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

3. K. Dubé. When Ethics Must Keep Up with Fast-Paced Biomedical Science: The Case of HIV Cure-Related Research. Invited lecture to the UNC Chapel Hill Parr Centers for Ethics – Ethics around the Table Series. February 2020. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

http://www.ncbi.nlm.nih.gov/pubmed/23691046http://core.ecu.edu/crawfordt/ncgs/ncg/ncg_2003/2003_dube.pdf



4. K. Dubé. Global Public Health Overview. Invited Lecture to Introduction to Public Health (SPHG 600). November 2019. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

5. B. Julg, L. Dee, K. Dubé. Analytical Treatment Interruptions in HIV Cure-Related Research. Invited webinar to the AIDS Clinical Trials Group (ACTG) Protocol Development and Implementation Sub-Committee, November 2019.

6. K. Dubé, S. Eskaf, D. Evans, J. Sauceda, P. Saberi, B. Brown, D. Averitt, K. Martel, M. Meija, D. Campbell, L. Barr, J. Kanazawa, K. Perry, H. Patel, S. Luter, T. Poteat, J.D. Auerbach, D.A. Wohl. Keeping HIV Under Control: A Cross-Sectional Survey on Preferences for Virologic Control Strategies among People Living with HIV (PLWHIV) in the United States. Oral presentation at 2019 American Public Health Association (APHA) meeting. November 2019, Philadelphia, PA, USA.

7. K. Dubé. Social Sciences and Ethics of HIV Cure. Invited oral presentation for 2019 Research-for-Cure Academy hosted by International AIDS Society (IAS) Towards an HIV Cure Initiative. November 2019, Wits Rural Facility, South Africa.

8. R. Gandhi, K. Dubé. HIV Cure Research: An Overview of ACTG’s Cure-Related Research and The Socio-Behavioral Aspects of Cure-Related Research. Invited webinar presentation for Community Partners and the Behavioral Science Working Group, October 2019.

9. D. M. Campbell, K. Dubé. Women and HIV Cure-Related Research. Invited webinar presentation for BEAT-HIV Collaboratory, October 2019.

10. K. Dubé. Global Public Health Overview. Invited Lecture to Introduction to Public Health (SPHG 600). July 2019. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

11. K. Dubé. How the Perspectives of People Living with HIV Influence (or Don’t) the Design of Clinical Research. The Case of HIV Cure. Invited oral presentation on ‘Community Engagement in HIV Research’ Symposia at 2019 International AIDS Society Conference on HIV Science, July 2019, Mexico City, Mexico.

12. K. Dubé. Integrating Social Sciences into BEAT-HIV Clinical Trials. Invited oral presentation at 2019 BEAT-HIV Collaboratory annual meeting, June 2019, Philadelphia, PA, USA.

13. K. Dubé. Women’s Interest in Participating in HIV Cure-Related Research and Results from A5366 Participant Surveys. Invited oral presentation to the 2019 AIDS Clinical Trials Group (ACTG) annual meeting, Women and HIV Cure Research Symposium, Cure Transformative Science Group (TSC) and Women’s Health Inter-Network Scientific Committee (WHISC), June 2019, Washington, D.C., USA.

14. K. Dubé. Socio-Behavioral Sciences and Ethics in HIV Cure-Related Research in the United States. A Review of Findings and Possibilities. Invited oral presentation to the 2019 AIDS Clinical Trials Group (ACTG) annual meeting, Protocol Development and Implementation Committee (PDISC) and Community Scientific Sub-Committee (CSS), June 2019, Washington, D.C., USA.

15. K. Dubé. End of Life Issues for People Living with HIV. Invited oral presentation to the 2019 AIDS Clinical Trials Group (ACTG) annual meeting, Mental Health and HIV Symposium, Neurology Collaborative Science Group (Neuro CSG), June 2019, Washington, D.C., USA.

16. K. Dubé, J. Taylor. The Last Gift. Update to Palm Springs Positive Life Program. Invited oral presentation to the Palm Springs Positive Life Program, May 2019, Palm Springs, CA, USA.

17. K. Dubé, S. Gianella. The Last Gift. Update to AntiViral Research Center. Invited oral presentation to the AntiViral Research Center, May 2019, San Diego, CA, USA.



18. K. Dubé. Integrating Social Sciences in HIV Cure-Related Research/Intégrer les Sciences Sociales sur la Recherche pour une Cure du VIH. Invited Oral Presentation at 2019 AIDS-ID Network Scientific Conference/Journées Québécoises du VIH, April 2019, Montréal, QC, Canada.

19. K. Dubé. Global Public Health Overview. Invited Lecture to Introduction to Public Health (SPHG 600). April 2019. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

20. K. Dubé. HIV Cure Science Update/Fundamentals of HIV Cure Research. Invited Oral Presentation for The Peter Doherty Institute for Infection and Immunity, INSPIRE (Improve, Nurture and Strengthen Education, Collaboration and Communication between PLWHIV and REsearchers), March 2019, Melbourne, Australia.

21. K. Dubé. Enhancing Meaningful Engagement of Women Living with HIV in Research. Invited Oral Presentation for Forum for Positive Women Victoria, March 2019, Melbourne, Australia.

22. K. Dubé, M. Louella. HIV Cure Research Ethics Update – Considerations for Cell and Gene Therapies. Invited Oral Presentation at 2019 Pre-CROI Community HIV Cure Research Workshop, March 2019, Seattle, WA, USA.

23. K. Dubé. Research Requiring Primary Data Collection. Invited Lecture to Essentials of Practice-Based Research (HPM 953). February 2019. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

24. K. Dubé. Global Public Health Overview. Invited Lecture to Introduction to Public Health (SPHG 600). November 2018. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

25. K. Dubé, D. Campbell, D. Evans. HIV Cure-Related Research. What Does it Mean for Cisgender and Transgender Women Living with HIV? Power Play: The Social and Scientific Impacts of Systematic Disclusion of Women Living With or at Risk for HIV: From Research to Praxis. Oral presentation at 2018 American Public Health Association (APHA) meeting. November 2018, San Diego, CA, USA.

26. K. Dubé. Social Sciences and Ethics of HIV Cure. Invited oral presentation for 2018 Research-for-Cure Academy hosted by International AIDS Society (IAS) Towards an HIV Cure Initiative. October 2018, Wits Rural Facility, South Africa.

27. K. Dubé. Social and Behavioral Sciences and Ethics Research: Critical Adjuncts to Ongoing Biomedical HIV Cure-Related Research Efforts. Invited webinar presentation for 2018 Community Meeting hosted by European AIDS Treatment Group (ETAG) adjacent to Glasgow HIV Drug Therapy Meeting, October 2018, Chapel Hill, NC USA and Glasgow, Scotland.

28. K. Dubé. A Community-Friendly Conversation on HIV Cure-Related Research: Hot Topics from Consensus Workshop on ATIs, IAS 2018 and 2018 NIH-Sponsored Workshop on HIV Cure. Invited webinar presentation for the I4C Martin Delaney Collaboratory Towards an HIV Cure, October 2018, Chapel Hill, NC, USA.

29. K. Dubé. Pathway in Global Public Health – From International Development to HIV Prevention and HIV Cure Research. Invited Lecture to Exploring Public Health (SPHG 620). October 2018. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

30. M. Hermerding, V. Mason, K. Dubé, D. Evans, P. Goicochea, V. Miller. Setting the Stage for Meaningful Community Engagement and Participation in HIV Cure-Related Research: Lessons Learned from the HIV Prevention Field. Oral presentation at HIV R4P (Research for Prevention) 2018, October 2018, Spain, Madrid.

31. J. Sauceda, K. Dubé. The Next Frontier in Socio-Behavioral Sciences and Ethics Research on HIV Cure. CAPS I&I Town Hall and Round Table Discussion. University of California San Francisco, October 2018, San Francisco, CA, USA.



32. K. Dubé, S. Luter, D. Evans. Acceptability of Target Product Profiles for an HIV Cure Regimen According to Adults Living with HIV in the United States. Invited oral presentation at 2018 NIH-sponsored workshop on HIV Cure, October 2018, Washington, D.C., USA.

33. M. Louella, L. Sylla, R. Boone, A.T. Young, K. Dubé. What Do We Mean When We Say ‘HIV Cure’? Community

engagement session in International AIDS Society (IAS) 2018 Global Village, July 2018, Amsterdam, The Netherlands.

34. K. Dubé. What Do We Need for Outreach, Recruitment, Retention, and Implementation of ACTG HIV Cure-Related Studies? Invited presentation for AIDS Clinical Trials Group (ACTG) Protocol Development and Implementation Sub-Committee (PDISC) annual meeting, June 2018, Washington, D.C., USA.

35. K. Dubé. Women’s Participation in HIV Cure-Related Studies: What is Needed to Mind the Gap? Invited presentation for AIDS Clinical Trials Group (ACTG) Women’s Health Inter-Network Scientific Committee (WHICS) annual meeting, June 2018, Washington, D.C., USA.

36. K. Dubé. Perceptions of People Living with HIV on HIV Cure-Related Research in the United States. Invited webinar for AIDS Clinical Trials Group (ACTG) Outreach, Recruitment and Retention (OR&R) Working Group. April 2018, United States.

37. K. Dubé. Ethical Issues in HIV Cure-Related Research. Invited webinar for Clarkson University Bioethics Program. April 2018, United States.

38. K. Dubé, S. Deeks, D. Evans, J. Sugarman. Social and Behavioral Sciences: A Critical Adjunct to Ongoing Biomedical HIV Cure Research Efforts. Invited Oral Presentation for Brown Bag Seminar Series, National Institutes of Health (NIH) Office of AIDS Research (OAR). March 2018, Bethesda, MD, USA.

39. K. Dubé. Research Requiring Primary Data Collection. Invited Lecture to Essentials of Practice-Based Research (HPM 953). March 2018. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

40. K. Dubé. Global Public Health Overview. Invited Lecture to Introduction to Public Health (SPHG 600). February 2018. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

41. K. Dubé, R. Ramaswamy. Great Decisions: Global Health Progress and Challenges. February 2018. Invited Lecture to Great Decisions Lecture Series (GLBL 381), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

42. K. Dubé. Perceptions of People Living with HIV on HIV Cure-Related Research in the United States. Invited

webinar presentation to AIDS Clinical Trials Group (ACTG) HIV Reservoirs and Viral Eradication Transformative Science Group (TSG). February 2018, United States.

43. K. Dubé. Ethical Issues in HIV Cure-Related Research in the United States. Invited Oral Presentation to HIV and

Global Health (HIGH) Rounds. February 2018, University of California San Diego, CA, USA.

44. K. Dubé. Ethical Issues in HIV Cure-Related Research in the United States. Invited Oral Presentation to Office of Research Integrity (ORI) Seminar Series. February 2018, University of California Riverside, CA, USA.

45. K. Dubé. Ethical Issues in HIV Cure-Related Research. Invited Oral Presentation to Positive Life Program. February 2018, Palm Springs, CA, USA.

46. K. Dubé. Ethical Issues in HIV Cure-Related Research at the End-of-Life. Invited Oral Presentation to AntiViral Research Center (AVRC) Community Advisory Board. February 2018, University of California San Diego, CA, USA.



47. K. Dubé. HIV Cure Research Update. World AIDS Day Event, International Civil Rights Center & Museum. Invited Oral Presentation, December 2017, Greensboro, NC, USA.

48. K. Dubé. Social Sciences Agenda in HIV Cure-Related Research in the United States. Invited Oral Presentation for the BEAT-HIV Collaboratory, Wistar Institute, November 2017, Philadelphia, PA, USA.

49. K. Dubé. HIV Cure-Related Research and the Socio-Behavioral Research Agenda. Invited Oral Presentation at Center for AIDS Research (CFAR) Social and Behavioral Research Network (SBSNR) 11th National Scientific Meeting, October 2017, San Francisco, CA, USA.

50. K. Dubé. Social Sciences in HIV Cure-Related Research. Where are We and Where Should we Go? Invited webinar presentation for the amfAR Institute for HIV Cure Research, October 2017, Chapel Hill, NC, USA.

51. K. Dubé. Translating HIV Cure Research Discoveries into People: A Community Conversation. Invited webinar presentation to Collaboratory of AIDS Researchers for Eradication (CARE), October 2017, Chapel Hill, NC, USA.

52. D. Campbell, J. Patterson, D. Evans, P. Goicochea, M. Agosto, D. Averitt, J. Salzwedel, C. Ramirez, K. Dubé. Where Are We with an HIV Cure Strategy for Women? Workshop at United States Conference on AIDS, September 2017, Washington, D.C., USA.

53. K. Dubé. Social Sciences in HIV Cure-Related Research: Where are We and Where Should be Go? Invited webinar presentation to the Delaney AIDS Research Enterprise (DARE), September 2017, Washington D.C., USA.

54. K. Dubé. Perceptions and Ethics of Treatment Interruptions in HIV Cure Research in the United States. Invited Oral Presentation at Cell and Gene Therapy Meeting, August 2017, Seattle, WA, USA.

55. K. Dubé. “From One Pill a Day to No Pill a Day:” Bridging Biomedical and Social Sciences in HIV Cure Research in the United States. Invited Oral Presentation at FHI 360, February 2017, Durham, NC, USA.

56. K. Dubé, D. Evans, L. Dee, L. Sylla, J. Taylor. Research into Community Perspectives on HIV Cure Science. Invited Oral Presentation at 2017 Pre-CROI Community HIV Cure Research Workshop, February 2017, Seattle, WA, USA.

57. K. Dubé. Opinions about HIV Cure Research among People Living with HIV in the United States. Invited Oral Presentation at 2016 Women’s HIV Research Initiative on HIV/AIDS (WRI) annual meeting, December 2016, Palmetto Bluff, South Carolina, USA.

58. L. Sylla, J. Taylor, D. Evans, D. Palm, A. Gilbertson, K. Dubé. HIV Cure Research: What Trial Participants Want

Researchers to Know. Oral presentation at the 2016 Cell and Gene Therapy Meeting, August 2016, Seattle, USA.

59. K. Dubé, J. Taylor, D. Evans, L. Sylla, L. Dee, A. Skinner, H. Thirumurthy, B. Weiner, S. Rennie, S. Greene. Factors Affecting Participation in HIV Cure-Related Research in the United States: Implications for Effective and Ethical Implementation. Oral presentation at the 2016 “Towards an HIV Cure Symposium”, July 2016, 2016 International AIDS Society, Durban, South Africa.

60. S. Rennie, S. Garner, K Dubé. Is It Ethical to Interrupt HIV Treatment in HIV Cure Research Studies? Oral

presentation at the 2016 Canadian Bioethics Society Conference, May 2016, Toronto, Canada.

61. K. Dubé, J. Taylor, D. Evans, L. Sylla, A. Burton, A. Skinner, S. Greene. Emerging Results of an Extensive Survey of Potential Participants' Willingness to Take Risks in and Donate to HIV Cure Research in the United States, 7th HIV Persistence Workshop, December 2015, Miami, FL, USA.

62. K. Dubé. Decoding HIV Cure Science: A CUREiculum Seminar. Oral Presentation at United States Conference on

AIDS, September 2015, Washington, D.C., USA.



63. K. Dubé. START Trial Results and Implications and Early Antiretroviral Therapy – A CUREiculum Presentation.

Invited Presentation at the Annual Meeting of the AIDS Clinical Trials Group (ACTG), June 2015, Washington, D.C.

64. K. Dubé. Examining Participation in HIV Cure Trials. What Can We Learn from the Proxy Literature? Oral Presentation at Brocher Foundation Workshop on “Unintended and Intended Implications of HIV Cure: A Social and Ethical Analysis.” May 2014, Geneva, Switzerland.

65. K. Nanda, F. Mirembe, K. Dubé, A. Lendvay, C. Kwok, L. Molife, S. Nakubulwa, V. Edward, S. Delany-Moretlwe.

Nevirapine-Containing ART Does Not Reduce Combined Oral Contraceptive Effectiveness: Results from South Africa and Uganda. Oral presentation 2012 International Virology Education Workshop on HIV and Women, February 2012, Toronto, Canada.

66. Zango, L. Bierhuizen, N. Veldhuijzen. A. Gova. F. Cumbe, K. Dubé, P. Feldblum, J. van de Wijgert. Men’s Willingness to Participate in Future HIV Prevention Trials in Beira, Mozambique. Oral presentation at Microbicides 2012, April 2012, Sydney, Australia.

67. R. Thompson, J. Ferro, S. Enosse, I. Meque, C. Muluana, A. Zango, P. Arnaldo, K. Dubé, T. Clifton, J. van de

Wijgert, P. Feldblum. Social and Epidemiological Characteristics of Women Most at Risk for HIV Infection in Mozambique. Oral presentation at 2011 INTEREST workshop, May 2011, Dar es Salaam, Tanzania.

Poster Presentations

1. K. Dubé, J. D. Auerbach, M. J. Stirratt, P. Gaist. From Reservoirs to the Real World. A Framework for Integrating Behavioral and Social Sciences Research into Biomedical HIV Cure-Related Research. Poster presentation at 2019 HIV Persistence During Therapy – Reservoirs & Eradication Strategies Workshop, December 2019, Miami, FL.

2. K. Perry, J. Taylor, S. Concha-Garcia, S. Javadi, H. Patel, A. Kaytes, S. Little, D. Smith, S. Gianella, K. Dubé. Behind the Scenes: Clinical and Rapid Autopsy Staff Members’ Experiences and Perceptions of HIV Reservoir Research at the End of Life. Poster presentation at 2019 HIV Persistence During Therapy – Reservoirs & Eradication Strategies Workshop, December 2019, Miami, FL.

3. B. Brown, L. Marg, Z. Zhang, D. Kuzmanović, K. Dubé, J. Galea. Factors Associated with Payments to Research Participations: A Review of Sociobehavioral Studies at a Large Southern California Research University. Poster presentation at 2019 Public Responsibility in Medical Research (PRIM&R), November 2019, Boston, MA.

4. J. S. Y. Lau, M. Z. Smith, B. Allan, K. Dubé, A. T. Yong, J. Power. The INSPIRE Project: Improving Community and Stakeholder Involvement in HIV Cure-Focused Research. Poster presentation at 2019 Australasian HIV & AIDS Conference, September 2019, Perth, Australia.

5. T. Poteat, K. Dubé, A. Aqil, D. Evans. Transgender Women’s Perceptions of HIV Cure Research: Qualitative Interviews with Transgender Women Living with HIV in Baltimore, MD, United States. Poster presentation at 2019 HIV & HBV Cure Forum, International AIDS Society Towards an HIV Cure Symposium, July 2019, Mexico City, Mexico.

6. K. Dubé, A. Nathan, K. Mathur, S. Concha-Garcia, H. Patel, A. Kaytes, J. Taylor, D. Smith, S. Gianella. Altruism in End of Life HIV Research: Insights from Last Gift Study. Posted presentation at 2019 Conference on Retroviruses and Opportunistic Infections (CROI), March 2019, Seattle, Washington, USA.

7. J. Simoni, L. Sylla, M. Louella, H. Patel, S. Luter, A.C. Collier, K. Dubé. Acceptability of Cell and Gene Therapies for Curing HIV: A Qualitative Investigation among Persons Living with HIV (PLWH) in the Northwestern United States. Poster presentation at 2018 NIH-sponsored workshop on HIV Cure, October 2018, Washington, D.C., USA.



8. K. Dubé, A. Nathan, S. Concha-Garcia, H. Patel, A. Kaytes, J. Taylor, D. Smith, S. Gianella. Extraordinary Altruism Displayed in HIV Cure-Related Research at the End of Life (EOL). Insights from Last Gift Study Participants. Poster presentation at 2018 NIH-sponsored workshop on HIV Cure, October 2018, Washington, D.C., USA.

9. K. Dubé, H. Patel, S. Concha-Garcia, A. Nathan, B. T. Miller, A. Kaytes, J. Taylor, D. Smith, S. Gianella. Perceptions of Next-of-Kin/Loved Ones about Last Gift Study Participation at the End of Life. Poster presentation at 2018 NIH-sponsored workshop on HIV Cure, October 2018, Washington, D.C., USA.

10. D. Evans, L. Sylla, J. Taylor, L. Dee, M. Louella, K. Dubé. The Critical Importance of Social Sciences in Early-Phase

HIV Cure Research: What’s in It for Biomedical HIV Cure Scientists? Poster presentation at 2017 HIV Persistence during Therapy – Reservoirs and Eradication Strategies Workshop, December 2017, Miami, FL, United States.

11. K. Dubé, L. Sylla, L. Dee, J. Taylor, D. Evans, C. Bruton, A. Gilbertson, L. Gralinski, B. Brown, A. Skinner, B.J.

Weiner, S.B. Greene, A. Corneli, A. Adimora, J.D. Tucker, S. Rennie. Towards a Translational Ethics of HIV Cure Research – Mapping the Landscape. Poster presentation at 2017 Global Health Triangle Consortium conference, September 2017, Raleigh, NC, United States.

12. K. Dubé, L. Sylla, D. Evans, J. Taylor, D. Palm, A. Gilbertson, J. D. Tucker, J. Auerbach. ‘From One Pill a Day to No Pill a Day’: Perceptions of HIV Cure Research among People Living with HIV – Qualitative Findings from Focus Groups in 4 U.S. Cities. Poster presentation at 2017 International AIDS Society conference, July 2017, Paris, France.

13. L. Sylla, M. Louella, D. Evans, D. Palm, R. Jefferys, K. Dubé. What Would an HIV Cure Mean to You? Ascribing Meaning through an HIV Cure Tree. Poster presentation at 2017 International AIDS Society conference, July 2017, Paris, France.

14. K. Dubé, J. Taylor, D. Evans, L. Sylla., L. Dee. Perceived Motivators, Deterrents, Concerns and Barriers Related to HIV Cure Research Participation in the United States: A Qualitative Study. Poster presentation at 2016 NIH-sponsored workshop on HIV Cure, November 2016, Washington, D.C., USA.

15. L. Sylla, D. Evans, J. Taylor, D. Palm., A. Gilbertson, K. Dubé. ‘We’re scared… and brave’: Potential Study

Participant Expectations of HIV Cure Researchers. Poster presentation at 2016 NIH-sponsored workshop on HIV Cure, November 2016, Washington, D.C., USA.

16. K. Dubé, B. Weiner, J. Taylor, S. Garner, S. Rennie. Is There an Implementation Ethics to HIV Cure-Related

Research? Poster presentation at 2016 AIDS conference, July 2016, Durban, South Africa.

17. D. Evans, J. Taylor, L. Sylla, S. Garner, B. Weiner, A. Skinner, S. Greene, S. Rennie, K. Dubé. Treatment Interruptions in HIV Cure Studies in the United States: Perceptions, Motivations and Ethical Considerations from Potential HIV-Positive Volunteers. Oral poster presentation at 2016 AIDS conference, July 2016, Durban, South Africa.

18. J. Taylor, D. Evans, L. Sylla, L. Dee, B. Weiner, A. Skinner, S. Greene, K. Dubé. Perceived Risks of Participating in

HIV Cure-Related Research in the United States. Poster presentation at 2016 AIDS conference, July 2016, Durban, South Africa.

19. J. Taylor, D. Evans, L. Sylla, L. Dee, B. Weiner, S. Greene, S. Rennie, K. Dubé. “What is “Too Much Risk” in HIV

Cure Clinical Research in the United States. Poster presentation at 2016 AIDS conference, July 2016, Durban, South Africa.

20. L. Sylla, J. Taylor, D. Evans, B. Weiner, A. Skinner, S. Greene, K. Dubé. Perceived Benefits of HIV Cure-Related

Research Participation in the United States. Poster presentation at 2016 AIDS conference, July 2016, Durban, South Africa.



21. J. Salzwedel, S. Hannah, J. Taylor, K. Dubé. Community Engagement in HIV Cure-Related Research: Applying

Good Participatory Practice (GPP) Principles to Community Education Efforts. Oral poster presentation at 2016 AIDS conference, July 2016, Durban, South Africa.

22. S. Garner, S. Rennie, J. Ananworanich, K. Dubé, D. Margolis, J. Sugarman, R. Tressler, A. Gilbertson, L. Dawson.

Interruption Antiretroviral Treatment in HIV Cure Research: Scientific and Ethical Considerations. Oral poster presentation at 2016 AIDS conference and poster presentation at “Towards an HIV Cure Symposium”, July 2016 Durban, South Africa.

23. K. Dubé, J. Taylor, R. Jefferys, M. Sharp, S. Wakefield, J. Handibode. Results of a Community Needs Assessment

and Pilot Test of a Novel HIV Cure Research Training Curriculum. Poster presentation at the 2015 “Towards an HIV Cure Symposium”, 2015 International AIDS Society, July 2015, Vancouver, Canada.

24. C. Garrido, J.M. Sung, N. Archin, B. Allard, K. Dubé, J. Kuruc, C. Gay, S. A. Stanfield-Oakley, J. Pickeral, J. Pollara,

C. LaBranche, M. Bonsignori, M. A. Moody, R. Parks, J. Blum, C.-Y. K. Lam, L. Liu, S. Johnson, S. Koenig, K. Sodenberg, H.X. Liao, D. Montefiori, J. Nordstrom, B. F. Haynes, G Ferrari, M. Cohen, D. Margolis. Dual Affinity Re-Targeting (DARTs) Molecules to Improve Immune Mediated Clearance of HIV Latent Reservoir. Poster presentation at 2014 NIH-sponsored Strategies for an HIV Cure meeting, October 2014, Bethesda, M.D., USA.

25. K. Nanda, V. Brache, C. Kwok, B. Tolley, A. Lendvay, K. Dubé. Continuous versus Cyclic Use of Combined Oral

Contraceptive Pills. Poster presentation at 2012 Society and Family Planning Conference, July 2012, Denver, CO, USA.

26. R. Thompson, S. Enosse, C. Muluana, P. Arnaldo, A. Nhanala, A. Bié, K. Dubé, P. L. Chen, M. Robb, K. Walker, P.

Feldblum. Measurement of HIV Incidence in a Higher-Risk Cohort in Southern Mozambique. Poster presentation at 2012 AIDS conference, July 2012, Washington, D.C., USA.

27. N.B. Bhatt, I.V. Jani, R. Thompson, J. Ferro, S. Enosse, A. Zango, K. Dubé, P. Feldblum, J. van de Wijgert, M. Robb,

K. Walker. Building Novel Clinical Research Capacity in Resource-Limited Settings: Lessons Learned at Three Mozambique Sites. Poster presentation at 2012 Drug Information Association (DIA) Conference, June 2012, Philadelphia, PA, USA.

28. Zango, K. Dubé, P.L. Chen, I. Meque, F. Cumbe, J. Ferro, S. Fischer, R. Krysiak, P. Feldblum, J. van de Wijgert. Correlations between CD4 Lymphocyte Counts and BED-CEIA HIV-1 Incidence Test Outcomes in Beira, Mozambique. Poster presentation at 2012 INTEREST workshop, May 2012, Mombasa, Kenya.

29. Meque, K. Dubé, A, Zango, P.L. Chen, F. Cumbe, J. Ferro, P. Feldblum, J. van de Wijgert. HSV-2 Infection among Women at Higher Risk for HIV Infection in Preparation for HIV Prevention Trials in Beira, Mozambique. Poster presentation at 2012 INTEREST workshop, May 2012, Mombasa, Kenya.

30. Meque, K. Dubé, A. Zango, P.L. Chen, J. Ferro, P. Feldblum, F. Cumbe, J. van de Wijgert. HIV Incidence Among Women at Higher Risk in Beira, Mozambique. Poster presentation at 2012 Microcrobicides, April 2012, Sydney, Australia.

31. K. Dubé, R. Thompson, I. Meque, S. Enosse, C. Muluana, A. Zango, J. Ferro, T. Clifton, J. van de Wijgert, P.

Feldblum. Unmet Need for Family Planning among HIV-Positive Women in Mozambique – Cross-Sectional Surveys in Beira and Chókwè. Poster presentation at 2011 IAS conference, July 2011, Rome, Italy.

32. Zango, P. Arnaldo, K. Dubé, R. Thompson, J. Ferro, S. Enosse, I. Meque, S. Fischer, J. van de Wijgert, P. Feldblum. Performance of a Rapid Test Algorithm for Confirming HIV Serostatus in Beira and Chókwè, Mozambique. Poster presentation at 2011 IAS conference, July 2011, Rome, Italy.



33. J. Ferro, I. Meque, A. Zango, S. Mussa, R. Rafael, K. Dubé, J. Conjera, J. Bos, P. Feldblum, J. van de Wijgert. Main Social and Epidemiological Features of Women Enrolled in a Cross-Sectional Survey in Beira, Mozambique. Poster presentation at 2010 INTEREST workshop, May 2010, Maputo, Mozambique.

34. R. Rafael, J. Conjera, S. Mussa, J. Ferro, I. Meque, K. Dubé, J. Bos, J. van de Wijgert, P. Feldlbum. Lessons Learned

from Community Recruitment into a Cross-Sectional Survey Involving HIV Testing in Beira, Mozambique. Poster presentation at 2010 INTEREST workshop, May 2010, Maputo, Mozambique.

35. K. Dubé, S. Mussa, A. Zango, I. Meque, J. Conjera, J. Ferro, J. Bos, P. Feldblum, J. van de Wijgert. Lessons Learned

from Building Research Capacity for Phase III HIV Prevention Trials in Beira, Mozambique. Poster presentation at 2010 Microbicides Conference, May 2010, Pittsburg, PA, United States.

Sample Blog Posts • How Do We Get to a Global Cure? (Positively Aware):

https://www.positivelyaware.com/articles/how-do-we-get-global-cure

• Highlights from the International AIDS Society HBV/HIV Cure Research Forum: https://www.positivelyaware.com/articles/highlights-ias-hbvhiv-cure-research-forum

• CROI 2019 HIV Cure Research Highlights: Has a Second Person Been Cured of HIV and 2019 Pre-CROI Community HIV Cure Research Workshop Summary (Positively Aware): https://www.positivelyaware.com/articles/hiv-research-highlights

• 2018 NIH Strategies for an HIV Cure – Meeting Highlights: https://www.positivelyaware.com/articles/2018-nih-strategies-hiv-cure

• IAS 2018 HIV Cure Research Highlights: https://www.positivelyaware.com/articles/aids-2018-hiv-cure-research-highlights

• Applying the Ethical Payment Framework: We Need Data: https://blog.primr.org/ethical-payment-framework-data/

• Mental Health Gets Special Emphasis at CROI 2018: https://www.positivelyaware.com/articles/mental-health-gets-special-emphasis-croi-2018

• Update from HIV Persistence 2017 – HIV Cure Scientific Highlights from the 2017 HIV Persistence Meeting: https://www.positivelyaware.com/articles/update-hiv-persistence-2017

• Positively Aware – HIV Cure Survey Results: We asked: ‘What Does a Cure for HIV Mean to You?: https://www.positivelyaware.com/articles/hiv-cure-survey-results

• Going into 2018: Reflections on Global Health Security: https://sph.unc.edu/global-health/going-into-2018-reflections-on-global-health-security/

• Carl June: Keynote at the 2017 Cell and Gene Therapy Meeting: http://searchiv.web.unc.edu/carl-june-keynote-2017-cell-gene-therapy-meeting/

• Snapshots of the 2017 Oxford Global Health and Bioethics International Conference: https://sph.unc.edu/global-health/snapshots-of-the-2017-oxford-global-health-and-bioethics-international-

conference

• IAS 2017: HIV and Cancer Fields United in Dialogue to Accelerate Discovery in the Search towards ‘Sustained Virologic Remission’: http://searchiv.web.unc.edu/ias-2017-hiv-cancer-fields-united-dialogue-accelerate-discovery-search-towards-sustained-virologic-remission/

https://www.positivelyaware.com/articles/how-do-we-get-global-curehttps://www.positivelyaware.com/articles/highlights-ias-hbvhiv-cure-research-forumhttps://www.positivelyaware.com/articles/hiv-research-highlightshttps://www.positivelyaware.com/articles/2018-nih-strategies-hiv-curehttps://www.positivelyaware.com/articles/aids-2018-hiv-cure-research-highlightshttps://blog.primr.org/ethical-payment-framework-data/https://www.positivelyaware.com/articles/mental-health-gets-special-emphasis-croi-2018https://www.positivelyaware.com/articles/update-hiv-persistence-2017https://www.positivelyaware.com/articles/hiv-cure-survey-resultshttps://sph.unc.edu/global-health/going-into-2018-reflections-on-global-health-security/http://searchiv.web.unc.edu/carl-june-keynote-2017-cell-gene-therapy-meeting/https://sph.unc.edu/global-health/snapshots-of-the-2017-oxford-global-health-and-bioethics-international-%09conferencehttps://sph.unc.edu/global-health/snapshots-of-the-2017-oxford-global-health-and-bioethics-international-%09conferencehttp://searchiv.web.unc.edu/ias-2017-hiv-cancer-fields-united-dialogue-accelerate-discovery-search-towards-sustained-virologic-remission/http://searchiv.web.unc.edu/ias-2017-hiv-cancer-fields-united-dialogue-accelerate-discovery-search-towards-sustained-virologic-remission/



TEACHING ACTIVITIES

Semester Course Number of Students

Summer 2020 The AIDS Course (PUBH 725) Public Health Leadership Program, UNC Chapel Hill (online)

TBD

Fall 2019 Critical Issues in Global Health (PUBH 711) Public Health Leadership Program and Global Health Concentration, UNC Chapel Hill (residential)

42


15

Spring 2019 Global Health Ethics (PUBH 712) Public Health Leadership Program, UNC Chapel Hill (online)

20

Fall 2018 Critical Issues in Global Health (PUBH 711) Public Health Leadership Program, UNC-Chapel Hill (online)

38


10

Spring 2018 Global Health Ethics (PUBH 712) Public Health Leadership Program, UNC Chapel Hill (online)

22

Fall 2017 Critical Issues in Global Health (PUBH 711) Public Health Leadership Program, UNC-Chapel Hill (online)

26

Fall 2017 Introduction to Global Public Health (SPHG 700) Public Health Leadership Program, UNC-Chapel Hill (online)

8

Spring 2017 Global Health Ethics (PUBH 712) Public Health Leadership Program, UNC-Chapel Hill (online)

25

Fall 2016 Introduction to Global Public Health (SPHG 700), Public Health Leadership Program, UNC-Chapel Hill (online)

20



STUDENT MENTORING Doctoral Dissertations

1. Joseph L. Barker, DrPH (Cohort 14), Optimizing Public Health Strategies to Increase HIV Testing Services among Men in Kenya, DrPH Dissertation Committee Member; under development.

2. Mayra Serrano, DrPH (Cohort 14), Assessing the Effectiveness of the Promotora Model to Increase Latino Participation in Cancer Research, DrPH Dissertation Committee Member; under development.

3. Olawale Durosinmi-Etti, DrPH (Cohort 13), Improving Funding Sustainability for HIV Treatment Services in Nigeria, DrPH Dissertation Committee Member; under development.

4. Courtney Lundquist, DrPH (Cohort 12), Achieving 90-90-90: Defining, Adapting, and Applying Lessons to Accelerate Goal Achievement, DrPH Dissertation Committee Member; successfully defended October 2019.

Graduate Teaching Assistants 2019

1. Dana Corbett, Critical Issues in Global Health (PUBH 711) 2. Elsa Sanabria, Global Health Ethics (PUBH 712) and AIDS Course Online (PUBH 725)

2018 2. Aninda Sen, Critical Issues in Global Health (PUBH 711) 3. Breanne Lesnar, Global Health Ethics (PUBH 712)

2017 4. Breanne Lesnar, Introduction to Global Public Health (SPHG 700) 5. Luke Newton, Critical Issues in Global Health (PUBH 711)

Graduate Research Assistants 2019

1. Karen Diepstra, PhD Candidate, UNC Epidemiology (R21- MH118120)

Research Assistants 2019 – Present

1. Kelly Perry, Public Health Leadership Program, UNC Gillings School of Global Public Health (Last Gift cohort) 2. Laney Henley, Bachelor’s in Biostatistics, UNC Gillings School of Global Public Health (A5345)

2018 – Present 3. Hursch Patel, Health Policy and Management, UNC Gillings School of Global Public Health (Last Gift cohort)

2018 – 2019 4. Anshula Nathan, Public Health Leadership Program, UNC Gillings School of Global Public Health (Last Gift

cohort) 5. Maria Ganama, Public Health Leadership Program, UNC Gillings School of Global Public Health (A5366)

2017 – Present 6. Stuart Luter, Health Policy and Management, UNC Gillings School of Global Public Health 7. Kushagra Mathur, University of California, San Diego (Last Gift cohort) 8. Sogol (Stephanie) Javadi, University of California, San Diego (Last Gift cohort) 9. Megan Lo, University of California, San Diego (Last Gift cohort)

Student Collaborators 2017 – 2018

1. Melissa Hermerding, University of California, Berkeley, Forum for Collaborative Research



Research Mentees 2020

1. Nimali Widanage, Sri Lanka Medical Council, Sri Lanka (2019 International AIDS Society Research-for-Cure Academy Fellow)

2. Samantha Fry, Stellenbosch University, South Africa (2019 International AIDS Society Research-for-Cure Academy Fellow)

2019

3. Danielle M. Campbell, Research Instructor, Charles R. Drew University (CDU) of Medicine and Science 4. Lentsu Nchabeleng, Nelson Mandela University, South Africa (2018 IAS Research-for-Cure Academy Fellow)

STUDENT ADVISING/MENTORING 1. Tandeka Burks, MPH at UNC (Online), Leadership in Practice (2020 – present) 2. Makala Carrington, MPH at UNC (Online), Leadership in Practice (2020 – present) 3. Madeline Pliska, MPH at UNC (Online), Leadership in Practice (2020 – Present) 4. Grace Anixter, MPH Residential Degree in Public Health Leadership – UNC Asheville (2019 – present) 5. Chandra Anjali, MPH at UNC (Online), Leadership in Practice (2019 – present) 6. Annie Lakey Becker, MPH at UNC (Online), Leadership in Practice (2019 – present) 7. Emily Cheng, MPH Residential Degree, Concentration in Global Health (2019 – present) 8. Cloie Chiong, MPH at UNC (Online), Leadership in Practice (2019 – present) 9. Patrick David Lilford Glasgow, MPH at UNC (Online), Leadership in Practice (2019 – Present) 10. Erica Liedtke, MPH Residential Degree in Public Health Leadership – UNC Asheville (2019 – present) 11. Jonathan Andrew Metz, MPH at UNC (Online), Leadership in Practice (2019 – Present) 12. Katerina Pattee, MPH Residential Degree, Concentration in Global Health (2019 – present) 13. Jennifer Page (Prater) Quesenberry, MPH at UNC (Online), Leadership in Practice (2019 – present) 14. Nadine Rammouni, MPH at UNC (Online), Leadership in Practice (2019 – present) 15. Alexandra Voss, MPH at UNC (Online), Leadership in Practice (2019 – present) 16. Kelly Perry, MPH at UNC (Online), Leadership in Practice (2019 – present) 17. Taylor LLyall, MPH at UNC (Online), Leadership in Practice (2019 – present) 18. Hector (Kenett) Melgar Mendoza, MPH Residential Degree in Public Health Leadership – UNC Asheville (2018 –

present) 19. Cat Turbyfill, MPH Residential Degree in Public Health Leadership – UNC Asheville (2018 – present) 20. Sarah Elizabeth Ashley, MPH Residential Degree in Public Health Leadership (2017 – 2019) 21. Erica Brierley, MPH Residential Degree in Public Health Leadership (2017 – 2018) 22. Rachel Davidson, Global Online (GO)TM MPH Program (2017 – present) 23. Grace Greene, Global Online (GO)TM MPH Program (2017 – present) 24. Mandy Horner, MPH Residential Degree in Public Health Leadership (2017 – 2018) 25. Victoria Pless, MPH Residential Degree in Public Health Leadership (2017 – 2019) 26. Mariana Rodriguez, MPH Online Degree in Public Health Leadership (2017 – present)



Master’s Papers Supervision: 2020

1. Courtney George: Title to be confirmed (Second reader). 2. John Kanazawa: Title To be confirmed (First reader). 3. Hannah Webster: “A Scoping Review and Comparison of International Media Attention and Local Media Contact

and Its Implications Associated with the 2015 Zika Outbreak in Latin America” (Second reader) 2019

1. Grace Greene: “Pre-Eclampsia amongst Pregnant Women in Haiti: The Impact of Micronutrient Supplementation” (First reader)

2. Rachel Davidson, “Baseline Assessment to Evaluate Attitudes, Norms, Knowledge, and Behaviors around Violence against Women and Girls and Evidence-Based Practices for the Curricula of a Faith-Based Youth Organization [in Kenya]” (First reader)

3. Sarah Elizabeth Ashley: “Developing Emergency Medicine Leaders for Public Health Outcomes in East Africa” (First reader)

4. Maria Ganama: “Sustainability of HIV/AIDS Treatment in Nigeria Through Domestic Production of Antiretroviral Treatment” (First reader)

5. Victoria Pless: “Reducing the Proportion of Children Living in Poverty in Dauphin County, Pennsylvania: A Program Plan Using Agile Strategy and Collective Impact” (First reader)

6. Anshula Nathan: “Undetectable = Untransmittable (U = U) Implementation in Rural North Carolina: Lessons Learned from Successful Rural Health Promotion and Education Campaigns” (Second reader)

7. Thomas Porter: “HIV Pre-Exposure Prophylaxis (PrEP) and Sexually Transmitted Infections (STI) Testing: Recommendations for Expanded Access and Public Health Implications in North Carolina” (Second reader)

2018 6. Erica Brierley: “Sexual Harassment Whistleblowing in the Uganda Health Workforce” (First reader)

OTHER MENTORING Teaching – Adjunct Faculty 2019

1. Christie Pettitt-Schieber, Adjunct Faculty, Public Health Leadership Program, Chapel Hill, NC. Undergraduate Students 2019 – Present

1. J. Eduardo Neri, Morehead-Cain Scholar (2017 – 2021), University of North Carolina, Chapel Hill, NC.



CONTRACTS AND GRANTS

Ongoing Research Support 11/01/2019 – present (0% effort) A Phase I Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121LS) Administered to HIV Infected Participants Who Initiated ART During Acute or Chronic HIV-1 Infection, AIDS Clinical Trials Group (ACTG) Study 5389 Role: Socio-Behavioral Scientist 10/01/2019 – present (5% effort) City of Hope (COH)/California Institute for Regenerative Medicine (CIRM) – Participant-Centered Outcomes for CMV-HIV Chimeric Antigen Receptor (CAR) T Cell Protocol (development phase) Role: Socio-Behavioral Scientist 07/01/2019 – present (5% effort) A Pilot Phase I Randomized Study to Evaluate Innate Immune Activation Predictors of Sustained Viral Control in HIV-Infected Adults Undergoing a Brief Analytical Treatment Interruption after the Administration of Pegylated Interferon Alpha 2b in Combination with Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-HIV Collaboratory) Role: Socio-Behavioral Scientist 05/01/2019 – 03/31/2021 (30% effort) Pilot Integration of Participant-Centered Outcomes in HIV Cure Research in the United States: Implications for Ethical Conduct (R21 MH118120) Role: Principal Investigator/Project Director 02/01/2019 – TBD (0% effort) The INSPIRE Project: Improve, Nurture and Strengthen Education, Collaboration, and Communication between People Living with HIV and REsearchers. In collaboration with the Australian Research Center in Sex, Health and Society, La Trobe University, Melbourne, Australia Role: Co-Investigator/Consultant/Socio-Behavioral Scientist 10/01/2018 – TBD (10% effort) Combinatorial Therapy with [CONFIDENTIAL]: A Pilot Study Aimed at Inducing an HIV Remission, UCSF/amfAR Institute for HIV Cure Research. Role: Socio-Behavioral Scientist 08/01/2018 – TBD (0% effort) A Phase 1, Open-Label, Study of the Safety, Pharmacokinetics and Ability to Durably Prevent Viral Relapse During a Monitored Analytical Treatment Interruption of a Combination of the Broadly Neutralizing Antibodies 3BNC117-LS and 10-1074-LS, AIDS Clinical Trials Group (ACTG) Study 5364 Role: Socio-Behavioral Scientist 08/01/2017 – 07/31/2022 (5% effort) Revealing Reservoirs during Rebound (R3) P01AI131385 Role: Socio-Behavioral Scientist 08/01/2017 – TBD (0% effort) Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control during an Intensively Monitored Antiretroviral Pause (IMAP), AIDS Clinical Trials Group (ACTG) Study 5345/5347s Role: Socio-Behavioral Scientist



08/01/2017 – TBD (0% effort) Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation with Histone Deacetylase Inhibitors, AIDS Clinical Trials Group (ACTG) Study 5366 Role: Socio-Behavioral Scientist

Completed Research Support 07/01/2017 – 04/30/2019 (5% effort) Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease in Liberia NIH R01 AI123535 Role: Research Support 03/01/2017 – 07/31/2017 ($USD 10,000 direct) Gilead Sciences/Project Inform Social Sciences of HIV Cure Research in the United States Role: Co-Investigator

02/02/2017 – 09/14/2017 ($USD 13,000 direct) Social and Ethical Implications of HIV Cure Research (searcHIV) NIH R01A108366 Role: Co-Investigator/Consultant 01/01/2016 – 06/30/2016 ($USD 5,000 direct) Martin Delaney Collaboratory National Community Advisory Board/University of California San Francisco (UCSF) Focus Group Implementation for Social Sciences in HIV Cure Research in 4 U.S. Cities (Seattle,CA; Los Angeles, CA; San Diego, CA; Durham, NC) Role: Principal Investigator 01/01/2016 – 06/30/2016 ($USD 14,479 direct) Martin Delaney Collaboratory National Community Advisory Board/University of California San Francisco (UCSF) Role: Co-Lead



Previous Work Experience and Research Protocol Involvement

Program Management of the Collaboratory of AIDS Researchers for Eradication (CARE) (2013 – 2015) Research Program Manager Responsibilities included provision of strategic and administrative direction to a large U.S. National Institutes of Health (NIH) Division of AIDS (DAIDS)-funded Collaboratory comprised of 20+ scientific projects from 10+ universities in the United States and Europe, together with industry partner Merck Inc. Main tasks pertained to overall grant management, fiscal management and oversight for cooperative agreement, management of internal communications including webinar series, coordination of scientific groups, production of operational reports and updates, coordination of external communications, including CARE Scientific Advisory Board, NIH, CARE Community Advisor Board (CAB) and other Martin Delaney Collaboratories, planning of face-to-face meetings; knowledge management including CARE-related publications and website, regular assessment of CARE investigators’ research progress, outcomes and collaboration; management of shared resources and reagents and coordination of legal and intellectual property rights agreement. The major focus of the CARE is on the development and testing of therapeutic interventions to eradicate latent HIV infection (www.delaneycare.org). Funded by the NIH DAIDS, Bethesda, United States. Cohort and Site Development to Assess the Incidence of HIV Infection, Retention Rate, and Willingness of Adults to Participate in Future HIV Vaccine Trials in Mozambique (2012 – 2013) Lead Clinical Research Associate Responsibilities included site development and capacity building, project management and elaboration of implementation plans, development of critical project documents, writing of manuscripts and scientific journal articles, development of general and study-specific training curriculums for site and cohort development project, communications with external partners. Funded by U.S. Department of Defense (DoD) and NIH DAIDS, Bethesda, United States. Clinical Site Development Initiative – Mozambique; Combined Cross-Sectional and Prospective Study for Measurement of HIV Incidence in Beira, Mozambique and in Chókwè, Mozambique (2008 – 2012) Project Manager/Senior Clinical Research Manager/Technical Monitor Responsibilities included site development and capacity building, management of study progress and implementation plans, development of critical study documents, submission for scientific and ethical reviews, elaboration and management of budgets and contracts, supervision of FHI 360/North Carolina and FHI 360/Mozambique staff, Good Clinical Practice (GCP) clinical monitoring, training of site staff, communication with external partners including the Amsterdam Institute of Global Health and Development (AIGHD)/AfrEVacc and the University of Pittsburgh (Beira), and the United States Military HIV Research Program (MHRP)/Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Centers for Disease Control and Prevention (CDC)/Mozambique. Funded by United States Agency for International Development (USAID); European and Developing Countries Clinical Trials Partnership (EDCTP), Amsterdam; U.S. MHRP, United States. Project Management of Interactions between Antiretrovirals and Combined Oral Contraceptive Pills (2008 – 2012) Co-Project Manager/Site Manager Responsibilities included development of study documents, project management, supervision of clinical monitors, GCP clinical monitoring of research site (Reproductive Health and HIV Research Unit (RHRU), Johannesburg, South Africa; Makerere University, Mulago Hospital, Kampala, Uganda). Funded by USAID, United States. Clinical Trial Project Management of a Double-Blind Randomized Placebo Controlled Dose-Finding Trial to Investigate Different Doses of a New Antiviral Drug in Subjects with Genital Herpes Simplex Virus (HSV) Type 2 Infection – Phase II (2009 – 2011) Co-Project Manager/Site Manager Responsibilities included development of procedures, processes and study documents, overall project operational management, GCP clinical monitoring of two research sites (Virology Research Clinic (VRC), University of Washington, Seattle and Westover Heights Clinic, Portland). Funded by AiCuris GmbH & Co. KG, Germany.

http://www.delaneycare.org/



Development of Assays for Acute HIV Infection and Estimation of HIV Incidence in Populations (2008 – 2010) Project Coordinator Responsibilities included organizing a meeting of experts on HIV incidence assays, generation of guidance documents on HIV incidence assays with the World Health Organization (WHO), development of HIV incidence library and management of sub-contracts. Funded by Bill and Melinda Gates Foundation, United States. Project Management of Continuous versus Cyclic Use of Combined Oral Contraceptive Pills (2008 – 2012) Co-Project Manager/Site Manager Responsibilities included development of procedures, processes and study documents, project management, GCP clinical monitoring of two research sites (Profamilia Clinic Santo Domingo, Dominican Republic and Profamilia Clinic, Managua, Nicaragua). Funded by USAID, United States. Clinical Trial Project Management of Medicines for Malaria Venture (MMV) Phase III Pyramax® trials (2008 – 2010) Project Manager/Clinical Trial Specialist Responsibilities included supervision of regional monitoring staff, management of project budgets, supervision of regulatory systems and project management of three malaria sister clinical trials in sub-Saharan Africa. Clinical Trial Research Management and Monitoring of Randomized Controlled Trial of 6% Cellulose Sulfate Gel for Prevention of HIV – Phase III (2005 – 2006) Clinical Research Manager/Monitor Responsibilities included preparation of study documents, GCP clinical monitoring of African sites (Makerere University, Mulago Hospital, Kampala, Uganda; Medical Research Council (MRC), Durban, South Africa; Project SIDA, Cotonou, Benin). Funded by Bill and Melinda Gates Foundation and CONRAD, United States.

UNIVERSITY SERVICE 2017 – Present UNC Gillings School of Global Public Health Global Health Concentration Committee 2017 – Present Curriculum Committee, Public Health Leadership Program 2017 – Present Emerging Leaders Program, UNC Gillings School of Global Public Health 2017 MPH Integrated Core Development Committee, UNC Gillings School of Global Public Health 2015 – Present UNC-CH Endorsement Committee for the Rhodes Scholarship 2015 – Present UNC-CH Morehead Scholarship Central Selection Committee 2010 – Present UNC-CH Center for AIDS Research Community Advisory Board 2010 – Present UNC-CH Golden Fleece Foundation Board of Directors

OTHER SERVICE/MEMBERSHIP 2019 – Present HIV Cure Target Product Profile (TPP) Working Group, International AIDS Society and Bill and

Melinda Gates Foundation 2019 – Present defeatHIV Collaboratory, Fred Hutchinson Cancer Research Center 2019 – Present AIDS Clinical Trials Group (ACTG) Transgender Working Group 2019 – Present Data Sharing Working Group on HIV Cure Research 2019 – Present BEAT-HIV Collaboratory, Wistar Institute 2018 ViiV Healthcare, CARLA Implementation Protocol Review 2018 – Present Mentor, Research-for-Cure Academy, International AIDS Society 2018 – Present Women’s HIV Research Collaborative (WHRC), Member, United States 2017 – Present International Social Sciences Working Group on HIV Cure Research 2017 – Present National Martin Delaney Community Advisory Board (CAB), At-Large Member, United States



EDITORIAL ACTIVITIES Associate Editor 2018 – Present BMC Public Health, Infectious Diseases Epidemiology Section Academic Editor 2018 – Present PLoS One Peer Reviewer AIDS AIDS and Behavior AIDS Patient Care and STDs American Journal of Empirical Bioethics (AJOB) BMC Public Health Drug and Alcohol Dependence Global Public Health HIV Medicine Journal of Acquired Immune Deficiency Syndromes (JAIDS) Journal of the International AIDS Society (JIAS) Military Medicine PLoS One

GRANT REVIEW 2019

• NIAID Clinical Trials Network Leadership and Operations Center (LOC) Re-competition (UM1 Clinical Trial Required)

• AIDS Fonds Research, Netherlands (2019 Grant Round)

• Réseau SIDA, Maladies Infectieuses, Canada (2019 – 2020 Grant Round)

• Réseau SIDA, Maladies Infectieuses, Canada (2018 – 2019 Grant Round)

karine dubÉ, drph...curriculum vitae – karine dubé page 3 of 25 2006 – 2007 program...

Documents